id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
663674,3cb907e2-d674-4e5a-bbdf-db181ad667f5,Q3,"TAKEDA PHARMACEUTICALS AMERICA, INC.",57954,TAKEDA PHARMACEUTICALS AMERICA INC,2008,third_quarter,HCR,"General diabetes legislative initiatives; Food and Drug Globalization Inspection bills; Uninsured and health reform issues; HR1038, HR5629, S1505, S1695 Follow On Biologics; HR6898 Health Information Technology; HR1424 Mental Health Equity Act; S1389, HR1113 Inflammatory Bowel Disease Research Act; HR3195 ADA Amendment Act; Evidence Based Medicine and Quality issues; S S3408 Comparative Effectiveness Research Act","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",,290000,0,0,2008-10-13T12:35:12-04:00